viatris semaglutide Novo-Emcure Deal Clever Counter To Indian Rivals, Follows Lilly-Cipla Pact Losing weight and keeping it off can lessen the many health risks that come with obesity Wegovy for the Treatment of

In 2024, life sciences stocks surged by 4.2%, adding USD 386 billion in value to reach a staggering USD 9.6 trillion, much of it driven by obesity-focused pharma companies

Individuals may experience weight regain after discontinuing weight-loss medications, but sustaining a healthier weight can often be achieved through ongoing healthy eating habits and regular exercise

Obesity Disease Burden and Population Health ROI Framework Economic Cost of Obesity, Comorbidity Cascade, and GLP-1 Pharmacotherapy Value-Based Evidence Reshape Global Treatment Investment The Global Obesity Forum estimated total annual economic costs of obesity at USD 4.32 trillion annually in 2025 , representing 2.92% of global GDP and exceeding the full economic output of Germany

Multiple molecular subtypes of GST have shown the ability to prevent skin, colon, and liver cancer initiation in mice exposed to carcinogens or lacking tumor suppressors ( Potential confounding factors, limited sample sizes, and other biases in observational studies make it difficult to derive an undetermined causal conclusion between antioxidants and cancers

If you have been prescribed Wegovy, you should know the risks of Wegovy interactions with certain drugs